Dear All,

Nirmal Bang is inviting you to a Zoom webinar.
When: Jun 18, 2021 08:45 AM India
Topic: Morning Market Update

Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_J4uP0jJOQ8ySggQNO30Ipg


After registering, you will receive a confirmation email containing information about joining the webinar.

PHARMEASY IS LIKELY IN TALKS FOR STAKE BUY IN THYROCARE WITH THE DEAL INCLUDING A VELUMANI INVESTING IN PHARMEASY’S OWNER API HOLDINGS - CNBC TV 18

*DB Corp Ltd.* | *CMP* Rs. 113 | *M Cap* Rs. 1977 Cr | *52 W H/L* 113/58
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 456.6 Cr (-7.6% QoQ, -6.2% YoY) vs QoQ Rs. 494.3 Cr, YoY Rs. 486.7 Cr
EBIDTA came at Rs. 101 Cr (-39% QoQ, 53.2% YoY) vs QoQ Rs. 165.6 Cr, YoY Rs. 65.9 Cr
EBITDA Margin came at 22.1% vs QoQ 33.5%, YoY 13.6%
Adj. PAT came at Rs. 61.9 Cr vs QoQ Rs. 99 Cr, YoY Rs. 24.1 Cr
Quarter EPS is Rs. 3.5
Share is trading at P/E of 8.2x FY22E EPS

https://youtu.be/IaBq486Rr6I

For more such interesting market insights, please subscribe to Nirmal Bang's YouTube channel.

HIMADRI SPECIALITY: CO CLRIFIES ON NEWS ITEM - “HSCL LIKELY TO ANNOUNCE STRATEGIC TIE UP WITH TESLA FOR BATTERIES” || CO SAYS CO IS IN NO SUCH DISCUSSIONS FOR ANY TIE UP WITH TESLA

*Power Mech Projects Ltd.* | *CMP* Rs. 710 | *M Cap* Rs. 1044 Cr | *52 W H/L* 726/354
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 755.2 Cr (48.5% QoQ, 27% YoY) vs QoQ Rs. 508.5 Cr, YoY Rs. 594.6 Cr
EBIDTA came at Rs. 74.5 Cr (238.4% QoQ, 14.5% YoY) vs QoQ Rs. 22 Cr, YoY Rs. 65.1 Cr
EBITDA Margin came at 9.9% vs QoQ 4.3%, YoY 11%
Adj. PAT came at Rs. 35.7 Cr vs QoQ Rs. 3.1 Cr, YoY Rs. 31.4 Cr
Quarter EPS is Rs. 24.2
Share is trading at P/E of 7.9x FY22E EPS

Daily Market Highlights | 17th Jun 2021 📊

NIFTY50: ₹15,691.40 | -0.48%

Top Gainers 📈

ULTRACEMCO: +1.69%
TCS: +1.64%
INFY: +1.39%
ASIANTPAINT: +1.36%
TECHM: +1.30%

Top losers 📉

ADANIPORTS: -8.99%
HINDALCO: -2.96%
INDUSINDBK: -2.96%
EICHERMOT: -2.63%
NTPC: -2.34%

Adani Group shares: Gautam Adani needs investors who have a website at least - The Economic Times - https://m.economictimes.com/markets/stocks/news/gautam-adani-needs-investors-who-have-a-website-at-least/articleshow/83593197.cms?utm_source=whatsapp_pwa&utm_medium=social&utm_campaign=socialsharebuttons

Follow this link to join my WhatsApp group: https://chat.whatsapp.com/KW2rP1KPs7TJw30A5BP4gL

*Fund Houses Recommendations*


CLSA on *HCL Tech*: Maintains Buy on company, target price at Rs 1160/Sh (Positive)

CLSA on *Lemon Tree*: Maintains Buy on company, target price at Rs 50/Sh (Positive)

Nomura on *Glenmark*: Maintains Buy on company, raise target price at Rs 762/Sh (Positive)

Nomura on *LIC Housing*: Maintains Buy on company, raise target price at Rs 625/Sh (Positive)

Jefferies on *Tata Steel*: Maintains Buy on company, target price at Rs 1500/Sh (Positive)

CLSA on *Tata Steel*: Maintains Buy on company, target price at Rs 1362/Sh (Positive)

Macquarie on *KEC*: Maintains Outperform on company, target price at Rs 490/Sh (Positive)

HSBC on *Indigo*: Maintains reduce on company, target price at Rs 1315/Sh (Neutral)

Exclusive | PharmEasy in talks to buy Thyrocare in deal worth around Rs 7,000 crore

https://www.moneycontrol.com/news/business/pharmeasy-in-talks-to-buy-thyrocare-in-deal-worth-around-rs-7000-crore-7048701.html

HIMADRI SPECIALITY: CO CLRIFIES ON NEWS ITEM - “HSCL LIKELY TO ANNOUNCE STRATEGIC TIE UP WITH TESLA FOR BATTERIES” || *CO SAYS CO IS IN NO SUCH DISCUSSIONS FOR ANY TIE UP WITH TESLA*

Securities in Ban For Trade Date 18-June-2021:

ADANIPORTS
BHEL
CANBANK
ESCORT
PNB

*Added No*
*Deleted NATIONALUM*

Lupin gets USFDA nod for Sevelamer tablets used for treatment of kidney disease - https://www.livemint.com/companies/news/lupin-gets-usfda-nod-for-sevelamer-tablets-used-for-treatment-of-kidney-disease-11623924898745.html


Download mint app for latest in Business News - https://bit.ly/32XEfFE

Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore

https://www.moneycontrol.com/news/business/pharmeasy-in-talks-to-buy-thyrocare-in-deal-worth-around-rs-7000-crore-7048701.html

Download moneycontrol app: http://m.moneycontrol.com/mom

VENUS REMEDIES LTD: CO A RESEARCH AND DEVELOPMENT-DRIVEN PHARMACEUTICAL MANUFACTURING COMPANY THURSDAY WON A 10-YEAR LONG LEGAL BATTLE THAT CHALLENGED PATENT CLAIMED BY FRENCH PHARMACEUTICAL FIRM SCR PHARMATOP - MINT

HFCL: CO TO BUILD PORTFOLIO OF 5G PRODUCTS FOR INDIAN, FOREIGN MARKETS - THE HINDU